Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/Ib Study of Azacitidine or Decitabine With Hedgehog Pathway Inhibition in Myeloid Malignancies

NCT02129101 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT02129101
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02129101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/Ib Study of Azacitidine or Decitabine With Hedgehog Pathway Inhibition in Myeloid Malignancies
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2014
Completion date
October 25, 2019
Enrollment
63 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myelomonocytic leukemia, de novo myelodysplastic syndrome, essential thrombocythemia, myelodysplastic syndrome, myelodysplastic/myeloproliferative neoplasm, polycythemia vera, previously treated myelodysplastic syndrome, primary myelofibrosis, recurrent adult acute myeloid leukemia, recurrent childhood acute myeloid leukemia, untreated adult acute myeloid leukemia